Abstract
With a surplus of nutritious and palatable foods and a reduced need for occupational physical labor, most Americans are finding weight control a major problem. The national mean body mass index (BMI) rises with each new survey, and obesity-related co-morbidities, such as type II diabetes mellitus, are reaching epidemic proportions (1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272: 205–211.
Krenkel J, Read M. Dietetic products and supplements. In: Obesity Assessment: Tools, Methods, Interpretations. St. Jeor ST, ed. New York: Chapman and Hall, 1997; 268–280.
Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. Obesity Res 1998; 6(Suppl. 2):51S–209S.
Ditschuneit H, Fletchner-Mors M, Johnson T, Adler G. Metabolic and weight loss effects of a long term dietary intervention in obese patients. Am J Clin Nutr 1999; 69: 198–204.
Heber D, Ashley J, Wang H, Elashoff R. Clinical evaluation of a minimal intervention meal replacement regimen for weight reduction. J Amer Coll Nutr 1994; 13: 608–614.
Position of the American Dietetic Association: weight management. J Am Diet Assoc 1997; 97: 71–74.
Bray GA. Contemporary Diagnosis and Management of Obesity. Handbooks in Health Care. PA: Newtown, 1998; 192–224.
Van Itallie TB, Yang MU. Cardiac dysfunction in obese dieters: a potentially lethal complication of rapid massive weight loss. Am J Clin Nutr 1984; 39: 695–702.
National Task Force on the Prevention and Treatment of Obesity, National Institutes of Health. Very low-calorie diets. JAMA 1993; 270: 967–974.
Wadden TA, Stunkard AJ, Brownell KD. Very low calorie diets: their efficacy, safety, and future. Ann Intern Med 1983; 99: 675–684.
Wadden TA, Sternberg JA, Letizia KA, Stundard AJ, Foster GD. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five year perspective. Int J Obes 1989; 13 (Suppl. 2): 39–46.
Foster GD, Wadden TA, Peterson FJ, Letizia KA, Bartlett SJ, Conill AM. A controlled comparison of three very-low-calorie diets: effects on weight, body composition, and symptoms. Am J Clin Nutr 1992; 55: 811–817.
Wadden TA, Foster GD, Letizia KA. One-year behavioral treatment of obesity: comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy. J Consul Clin Psych 1994; 62: 165–171.
McCarron D, et al. Nutritional management of cardiovascular risk factors. Arch Internal Med 1997; 157: 169–177.
Mattson FH, Volpenheim RA. Hydrolysis of fully esterified alcohols containing from one to eight hydroxyl groups by the lipolytic enzymes of rat pancreatic juice. J Lipid Res 1972; 13: 325–328.
Lawson KD, Middleton SJ, Hassall CD. Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review. Drug Metab Rev 1997; 29: 651–703.
Freston JW, Ahnen DJ, Czinn SJ, Earnest DL, Farthing MJ, Gorbach SL, et al. Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms. Reg Toxicol Pharmacol 1997; 26: 210–218.
Bergholz CM. Safety evaluation of olestra, anon-absorbed, fatlike fat replacement. Crit Rev Food Sci Nutr 1992; 32: 141–146.
Bernhardt CA. Olestra-a non-caloric fat replacement. Food Tech Intl Europe 1988; 176–178.
Institute of Food Science and Technology. Current Hot Topics: Olestra. Position Statement, 1996.
Prince DM, Welschenbach MA. Olestra: a new food additive. J Am Diet Assoc 1998; 98: 565–569.
Peters JC, Lawson KD, Middleton SJ, Triebwasser KC. Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: summary. J Nutr 1997; 127: 1719S - 1728S.
Cheskin LJ, Miday R, Zorich N, Filloon T. Gastrointestinal symptoms following consumption of olestra or regular triglyceride potato chips: a controlled comparison. JAMA 1998; 14: 150–152.
Zorich NL, Biedermann D, Riccardi KA, Bishop LJ, Filloon TG. Randomized, double-blind, placebo-controlled, consumer rechallenge test of Olean salted snacks. Regul Toxicol Pharmacol 1997; 26: 200–209.
Sandler RS, Zorich NL, Filloon TG, Wiseman HB, Lietz DJ, Brock MH, Royer MG, Miday RK. Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial. Ann Intern Med 1999; 130: 253–261.
Rock CL, Thornquist MD, Kristal AR, Patterson RE, Cooper DA, Neuhouser ML, Neumark-Sztainer D, Cheskin LJ. Demographic, dietary and lifestyle factors differentially explain variability in serum carotenoids and fat-soluble vitamins: baseline results from the sentinel site of the Olestra Post-Marketing Surveillance Study. J Nutr 1999; 129: 855–864.
Josefson D. Fat substitute declared safe. Br Med J 1998; 316: 1926.
Glueck CJ. Sucrose polyester, cholesterol, and lipoprotein metabolism. In: Carbohydrate Polyesters as Fat Substitutes. Akoh CC, Swanson BG, eds. New York: Marcel Dekker, 1994; 169–182.
Blackburn H. Olestra and the FDA. N Engl J Med 1996; 334: 984–986.
Campbell RG, Hashim SA, Van Itallie TB. Studies of food-intake regulation in man. Responses to variations in nutritive density in lean and obese subjects. N Engl J Med 1971; 16: 1402–1407.
Yang MU, Van Itallie TB. Effect of energy restriction on body composition and nitrogen balance in obese individuals. In: Treatment of the Seriously Obese Patient. Wadden TA, Van Itallie TB, eds. New York: Guilford, 1992; 83–106.
Birch LL, Deysher M. Caloric compensation and sensory specific satiety: evidence for self regulation of food intake by young children. Appetite 1986; 7: 323–331.
Birch LL, Johnson SL, Jones MB, Peters JC. Effects of a non-energy fat substitute on children’ s energy and macronutrient intake. Am J Clin Nutr 1993; 58: 326–333.
Cotton JR, Weststrate JA, Blundell JE. Replacement of dietary fat with sucrose polyester: effects on energy intake and appetite control in nonobese males. Am J Clin Nutr 1996; 63: 891–896.
Rolls BJ, Pirraglia PA, Jones MB, Peters JC. Effects of olestra, a noncaloric fat substitute, on daily energy and fat intakes in lean men. Am J Clin Nutr 1992; 56: 84–92.
Burley VJ, Blundell JE. Evaluation of the action of a nonabsorbable fat on appetite and energy intake in lean healthy males. In: Obesity in Europe 91. Ailhaud G, et al., eds. London: John Libbey, 1992; 63–65.
Hulshof T, de Graaf C, Weststrate JA. Short-term satiating effect of the fat replacer sucrose polyester (SPE) in man. Br J Nutr 1995; 74: 569–585.
Cotton JR, Burley VJ, Weststrate JA, Blundell JE. Fat substitution and food intake: effect of replacing fat with sucrose polyester at lunch or evening meals. Br J Nutr 1996; 75: 545–556.
Geliebter A. Effects of equicaloric loads of protein, fat and carbohydrate on food intake in the rat and man. Physiol Behav 1979; 22: 267–273.
De Graaf C, Hulshof T, Weststrate JA, Hautvast JG. Nonabsorbable fat (sucrose polyester) and the regulation of energy intake and body weight. Am J Physiol 1996; 270: R1386–1393.
Glueck CJ, Jandacek R, Hogg E, Allen C, Baehler L, Tewksbury M. Sucrose polyester: substitution for dietary fats in hypocaloric diets in the treatment of familial hypercholesterolemia. Am J Clin Nutr 1983; 37: 347–354.
Hill JO, Seagle HM, Johnson SL, Smith S, Reed GW, Tran ZV, et al. Effects of 14 d of covert substitution of olestra for conventional fat on spontaneous food intake. Am J Clin Nutr 1998; 67: 1178–1185.
Kendall A, Levitsky DA, Strupp BJ, Lissner L. Weight loss on a low-fat diet consequence of the imprecision of the control of food intake in humans. Am J Clin Nutr 1991; 53: 1124–1129.
Sheppard L, Kristal AR, Kushi LH. Weight loss in women participating in a randomized trial of low-fat diets. Am J Clin Nutr 1991; 54: 821–828.
Miller DL, Castellanos VH, Shide DJ, Peters JC, Rolls BJ. Effect of fat-free potato chips with and without nutrition labels on fat and energy intakes. Am J Clin Nutr 1998; 68: 282–290.
Hampl JS, Sheeley AE, Schnepf MI. Sounding the alarm for misuse of olestra-containing foods in binge-eating disorders J Am Diet Assoc 1998; 98: 971.
Stampfer MJ, Willett WC. Olestra and the FDA. N Engl J Med 1996; 335: 669–670.
Weststrate JA, van het Hof KH. Sucrose polyester and plasma carotenoid concentrations in healthy subjects. Am J Clin Nutr 1995; 62: 591–597.
Middleton SJ, Dwyer J, Peters JC. An indirect means of assessing potential nutritional effects of dietary olestra in healthy subgroups of the general population. J Nutr 1997; 127: 1710–1718S.
Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Related Metab Disord 1998; 22: 39–47.
Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res 1997; 5: 542–548.
Astrup A, Toubro S, Raben A, Skov AR. The role of low-fat diets and fat substitutes in body weight management: what have we learned from clinical studies? J Am Diet Assoc 1997; 97: S82–87.
Prentice AM, Jobb SA. Obesity in Britain. Gluttony or sloth. Br Med J 1995; 311: 437–439.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Geliebter, A., Funkhouser, A., Heymsfield, S.B. (2001). Meal Replacement Products and Fat Substitutes in Weight Control and Maintenance. In: Bendich, A., Deckelbaum, R.J. (eds) Primary and Secondary Preventive Nutrition. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-039-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-59259-039-1_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-173-8
Online ISBN: 978-1-59259-039-1
eBook Packages: Springer Book Archive